Threshold Pharmaceuticals
Harold E. Selick, Ph.D.,
Chief Executive Officer
Tillman Pearce, M.D.,
Chief Medical Officer
Mark D. Matteucci, Ph.D.,
Senior Vice President of Discovery Research
Robert L. Simon,
Senior Vice President of Regulatory Affairs and Quality Assurance
Stewart M. Kroll,
Senior Vice President of Clinical Operations and Biostatistics
Charles P. Hart, Ph.D.,
Vice President of Biology
Eric D. Malek, MBA,
Vice President of Corporate Development
Joel A. Fernandes,
Vice President of Finance and Controller
Nipun Davar, Ph.D., MBA,
Vice President of Pharmaceutical Development and Manufacturing
Jeffrey W. Bird, M.D., Ph.D.,
Managing Director, Sutter Hill Ventures, Inc.
Bruce C. Cozadd,
Chairman and Chief Executive Officer, Jazz Pharmaceuticals plc
David R. Hoffmann,
Chief Executive Officer, Hoffmann Associates
Wilfred E. Jaeger, M.D.,
Partner, Three Arch Partners
George G. C. Parker, Ph.D.,
Dean Witter Distinguished Professor of Finance and Management,
Graduate School of Business,
Stanford University
David R. Parkinson, M.D.,
Venture Partner, New Enterprise Associates
Harold E. Selick, Ph.D.,
Chief Executive Officer, Threshold Pharmaceuticals, Inc.